Why Bajaj Finance fell 3% even after big profit jump

Why did Bajaj Finance shares fall after a 29% profit jump?

Investors price what comes next, not just the last quarter. Even with profit up 29% to Rs 6,367 crore, rising interest rates threaten Bajaj Finance's lending margin, and some short-term gold loans are showing stress. Brokerages trimmed earnings forecasts, and a planned Rs 17,500 crore share sale (a new stock issue that could dilute existing holders) could dilute existing holders. So the stock fell nearly 3% on October 21, 2026.

Why worry about rising rates when profits still grow?

Bajaj Finance earns its margin by borrowing at one rate and lending at a higher one. When the Reserve Bank (India's central bank) raises rates, its funding costs can climb faster than it can reprice loans, squeezing that gap. Nomura trimmed its FY28-29 earnings estimates by 2-3%, citing NIM headwinds, even as loans grew 26%. Investors are pricing that future squeeze into today's share price.

How do brokerages still call the stock a buy if they cut their forecasts?

Buy ratings and lower targets are not contradictory. Jefferies kept its Buy call but trimmed estimates due to gold-loan stress, flexi-loan terms and insurance fee uncertainty, expecting 25% profit growth over FY26-29. Nomura maintained Buy with a Rs 1,270 target after cutting FY28-29 EPS by 2-3% on margin pressure. A lower target only means less upside than before, not a bearish view. All see the stock appreciating, just more slowly than earlier thought. Our read: these cuts are calibrations, not reversals, and reflect confidence in the long-term franchise despite near-term headwinds.

Why would a company raise funds right when its margins are under pressure?

Bajaj Finance approved raising Rs 17,500 crore through a qualified institutional placement and warrants to promoter Bajaj Finserv, its first equity raise since November 2023. The funds are intended for its next phase of growth, which management signaled by raising FY27 loan growth guidance to 26-27%. While new equity can dilute existing shareholders, the capital also lets the company keep lending aggressively even as funding costs rise. Our read: this is a growth bet, not a distress call, funded while the stock still trades near record levels.

Why is the company borrowing so much if profits are already strong?

Bajaj Finance is raising Rs 17,500 crore through a QIP and warrants to Bajaj Finserv, its first equity raise since November 2023. The funds back its raised FY27 loan growth guidance of 26-27%. New capital supports lending expansion, but it also dilutes existing holders. The timing matters: borrowing is cheap while the stock trades near record levels, so the company gets more money per share. Our read: this is a deliberate growth bet funded when equity is attractively priced, not a cash crunch.

Who actually pays for the share sale's dilution?

The dilution falls on existing shareholders, who now own a smaller slice of the company after the Rs 17,500 crore raise. But the money goes into funding new loans, which grew 26% and are expected to keep growing at 26-27% next year. If that growth earns more than the cost of the new equity, the bigger pie can offset the smaller slice. Our read: long-term holders bear dilution now for growth that the stock's record price makes worth funding.

Does the dilution matter if the capital is for growth?

The growth funded by the Rs 17,500 crore raise must earn more than the cost of the new equity for the dilution to be worth it. Nomura assumes the raise completes in FY27 and still expects return on equity of 19.9% over FY28-29, well above typical equity costs. If loan growth sustains at 26-27% and margins hold, the larger loan book can offset the smaller ownership slice. Our read: the dilution is the price of growth, not a sign of weakness, and long-term holders should judge it by whether returns stay high.

Why borrow at record share prices instead of waiting for better terms?

Bajaj Finance is raising Rs 17,500 crore through a QIP and warrants because it wants the capital now for its next growth phase, with FY27 loan growth guidance raised to 26-27%. The timing is deliberate: issuing equity when the stock trades near record levels means it sells fewer shares for the same money, limiting dilution. Nomura expects the raise to complete in FY27. Our read: the company is pricing the sale while its shares are attractive, not waiting for a potentially worse market.

What could change investors' minds in the coming months?

Watch two things: whether lending yields keep pace with funding costs, protecting net interest margins, and whether stress in short-term gold loans spreads. Bajaj Finance raised its FY27 growth guidance to 26-27%, but growth must not weaken credit standards. Regulatory decisions on revolving credit (a line of credit that can be used repeatedly) and insurance fees also remain pending. Our read: asset quality and margins, not growth, will decide the share price.

What exactly is squeezing the margin from rising rates?

Bajaj Finance borrows at short-term rates and lends at longer ones. When the RBI raises rates, its funding costs reprice upward quickly, while many existing loans carry fixed rates that reset slowly. That timing gap narrows the net interest margin, the difference between interest earned and paid. Nomura flagged marginal NIM headwinds from this dynamic, trimming its earnings estimates even though loan growth stayed at 26%. Investors sell because a smaller margin on a growing loan book still means less profit than previously expected.

Why did investors sell despite strong results?

Investors didn't sell because of past results; they worried about what comes next. Bajaj Finance borrows money to lend, and with the Reserve Bank (India's central bank) raising interest rates, its borrowing costs may rise faster than what it earns from loans, squeezing margins. Combined with stress in short-term gold loans, regulatory uncertainty over costs, and a planned Rs 17,500 crore share sale (a new stock issue that could dilute shareholders) that could dilute shareholders, brokerages trimmed earnings estimates even as profit grew 29%.

How can the company tell if the squeeze is actually happening?

The earnings report shows net interest income, the gap between interest earned on loans and interest paid on borrowings. In Q2 FY27, that rose 24% year-on-year, slower than the 26% growth in loans, a sign margins are already thinning even before analysts flagged headwinds from rising rates. Investors should watch whether that gap keeps narrowing in coming quarters, which would confirm the squeeze is real and not just a forecast.

Why would a lender raise its growth target when margins are already thinning?

Bajaj Finance lifted its FY27 loan growth guidance to 26-27% from 22-24%, signalling confidence in demand for consumer and small-business loans. Yet net interest income grew 24% against 26% loan growth, showing margins compressing. Management expects MSME book to grow double-digit in H2 FY27. Our read: growth is the lever to offset thinner margins, but only if credit standards hold, since rapid expansion with weak underwriting would worsen asset quality and amplify the squeeze.

If growth is the offset, why are brokerages still cutting profit estimates?

Nomura trimmed FY28-29 earnings per share by 2-3% and Jefferies lowered its target, despite the raised growth guidance. They are not doubting loan demand; they are pricing in costs that rise with growth. Nomura assumes the Rs 17,500 crore capital raise completes in FY27, which dilutes earnings per share, while Jefferies flags gold-loan stress and regulatory fees. Our read: the cuts are about the cost of delivering that growth, not about growth itself.

If the squeeze is real, when does the market actually see it?

The squeeze shows up in the company's quarterly reports well before the market fully believes it. In Q2 FY27, net interest income grew 24% while loans grew 26%, a gap analysts flagged as a margin headwind. Brokers like Nomura and Jefferies trimmed earnings estimates because they expect this gap to persist or widen in a rising-rate environment. The stock fell 3% on results day, showing investors took the warning seriously. Our read: the market was pricing the squeeze into the share price on the day, not waiting for it to appear in future earnings.

If the market already priced in the squeeze, why do targets stay so high?

All five brokerages cited kept Buy ratings with targets of Rs 1,175 to Rs 1,270, implying 23% to 33% upside from the post-results price, even after trimming estimates. They expect profit to keep compounding at around 25% annually through FY29, with return on equity near 20%. The cuts were small, 2 to 3% of EPS, because the margin squeeze is expected to be modest, not fatal. Our read: the targets say the squeeze trims growth, it does not stop it, so the stock still looks cheap to them.

If the squeeze is modest, why are brokers cutting, not raising, targets?

Because a modest squeeze still reduces what the same profit is worth. Jefferies trimmed its target to Rs 1,230 from Rs 1,280 and Nomura cut FY28-29 EPS by 2-3%, yet both kept Buy ratings, expecting 25% profit CAGR through FY29 with return on equity near 20%. The cuts reflect slightly slower compounding and lower valuation multiples, not a broken model. Our read: they are recalibrating the price of the same good story, not doubting the story itself.

Why are analysts worried about Bajaj Finance margins?

Bajaj Finance borrows money to lend at a higher rate; the gap is its margin. As the Reserve Bank (India's central bank) raises interest rates, borrowing costs rise. Analysts worry the company cannot raise loan rates fast enough to keep this gap intact. Nomura flagged “marginal headwinds” on margins in the rising-rate environment, trimming earnings estimates for FY28-29 by 2-3%.

Why would a capital raise spook investors even if the business is growing?

Bajaj Finance has approved raising Rs 17,500 crore, its first equity raise since 2023. New equity can dilute existing shareholders' ownership, so even if the money funds growth, the earnings per share each investor gets can shrink. Nomura's estimate cuts of 2-3% for FY28-29 already assume the raising is completed in FY27. Our read: the dilution is priced in as a cost of next-phase growth, not as a sign the company is struggling.

If all analysts still say Buy, why does the share price keep falling?

A Buy rating means the stock should rise eventually, but the target price is only an estimate of where it will go. Jefferies cut its target from Rs 1,280 to Rs 1,230, Nomura kept Rs 1,270, and Axis trimmed to Rs 1,255, all while keeping Buy calls. So the expected upside is smaller than before. Investors also weigh risks like gold-loan stress and regulatory changes, which target prices may not fully capture. Our read: the market is paying attention to the shrinking gap between price and target, not just the Buy label.

What would actually make the target prices wrong, not just revised?

The targets all assume roughly 25% compound annual profit growth through FY29, with Nomura expecting return on assets of 4.2% and return on equity of 19.9% over FY28-29. Those figures depend on margins holding, gold-loan stress staying contained, and regulatory changes on revolving credit and insurance fees being benign. Asset quality has improved, with gross NPA down to 1.06% from 1.24%, but short-term gold loans show early stress. Our read: a sharper margin squeeze or a gold-loan stress spread would break the profit-growth assumption itself, forcing target cuts far larger than the 2-3% estimate trims seen so far.

If profit is still growing at 29%, why does a bigger margin squeeze matter so much?

Because the growth is borrowed from the future. Nomura cut FY28-29 earnings estimates by 2-3% and expects return on assets of just 4.2%, while Jefferies expects profit to compound at 25% through FY29. The share price reflects what investors think the next three years will earn, not last quarter. A margin squeeze that shaves even 2-3% off future earnings directly reduces the value of those future profits. Our read: the 29% jump is already priced in; what the market is paying for is whether that pace can hold, and any crack in margins threatens the whole growth story.

Is the whole market in this kind of squeeze, or just Bajaj?

The bigger picture shows the squeeze is not unique to Bajaj Finance. Consensus FY27 profit growth estimates for top 200 companies fell from 15.5% in October 2025 to 9.2% by September 2026, and financials dropped from 15.3% to 14.0%. FY28 estimates for financials are steady at 15.1%, but the overall market's forward growth has slowed sharply. Our read: Bajaj's 25% expected profit growth stands far above the sector average, which is why the stock has outperformed the Nifty, which has fallen 14% this year despite Bajaj rising 2%.

If Bajaj Finance is growing faster than its peers, why is its stock barely up this year?

Outperformance is relative, not absolute. Bajaj Finance shares rose about 2% in 2026 while the Nifty fell 14%, meaning the market is rewarding it with a smaller decline, not a rally. That gap exists because investors still see the same risks as a year ago: rising funding costs squeezing margins, early stress in short-term gold loans, and pending regulatory changes on revolving credit and insurance fees. Strong profit growth has kept the stock from falling with the market, but those unresolved risks cap its upside until they clear. Our read: the market is paying Bajaj for stability, not acceleration.

What would have to go right for the stock to climb to those targets?

The targets assume several things hold. First, net interest margins must not shrink much as borrowing costs rise, so lending yields need to keep pace. Second, the stress in short-term gold loans must stay contained, with asset quality stable. Third, pending regulatory decisions on revolving credit and insurance fees need to be benign for fee income. Nomura and Jefferies both expect roughly 25% compound annual profit growth through FY29. Our read: if any of these three assumptions cracks faster than expected, the targets will be revised down again.